Cognex (NASDAQ:CGNX) Stock Gets Price Target Bump from Barclays

Key Points

• Barclays raised its Cognex price target from $80 to $85 and maintained an “overweight” rating, implying 37.6% upside from the stock’s $61.77 price.
• Analyst sentiment is broadly positive: Cognex has a “Moderate Buy” consensus rating and an average price target of $75.57, although several firms maintain “hold” ratings.
• Cognex recently exceeded quarterly EPS expectations, reporting $0.45 versus the $0.42 consensus, while revenue rose 16.9% year over year; institutional investors own 88.12% of the stock.

Cognex (NASDAQ:CGNX - Get Free Report) had its target price upped by research analysts at Barclays from $80.00 to $85.00 in a report issued on Monday, Benzinga reports. The firm presently has an "overweight" rating on the scientific and technical instruments company's stock. Barclays's price target indicates a potential upside of 37.60% from the stock's current price.

Other research analysts also recently issued research reports about the company. Needham & Company LLC reaffirmed a "buy" rating and issued a $80.00 price objective on shares of Cognex in a research note on Tuesday, September 15th. Robert W. Baird reduced their target price on shares of Cognex from $78.00 to $70.00 and set a "neutral" rating for the company in a report on Wednesday, September 23rd. HSBC lowered shares of Cognex from a "buy" rating to a "hold" rating and set a $65.00 target price for the company. in a report on Monday, August 10th. The Goldman Sachs Group restated a "buy" rating and set a $91.00 target price on shares of Cognex in a research note on Friday, August 7th. Finally, Cantor Fitzgerald lifted their price target on shares of Cognex from $76.00 to $84.00 and gave the company an "overweight" rating in a report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $75.57.

Cognex Price Performance

Shares of NASDAQ:CGNX traded down $1.15 during trading on Monday, hitting $61.77. The company's stock had a trading volume of 546,671 shares, compared to its average volume of 2,129,634. The company has a 50-day moving average of $62.18 and a 200-day moving average of $61.36. Cognex has a 12 month low of $34.60 and a 12 month high of $72.88. The firm has a market cap of $10.39 billion, a price-to-earnings ratio of 60.04 and a beta of 1.48.

Cognex (NASDAQ:CGNX - Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.42 by $0.03. Cognex had a net margin of 16.05% and a return on equity of 13.50%. The company had revenue of $291.26 million for the quarter, compared to the consensus estimate of $292.10 million. During the same quarter last year, the firm posted $0.25 earnings per share. The firm's revenue was up 16.9% compared to the same quarter last year. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. As a group, research analysts anticipate that Cognex will post 1.68 earnings per share for the current year.

Institutional Trading of Cognex

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. IFP Advisors Inc lifted its stake in Cognex by 21.6% in the 2nd quarter. IFP Advisors Inc now owns 956 shares of the scientific and technical instruments company's stock worth $69,000 after purchasing an additional 170 shares in the last quarter. State of Michigan Retirement System boosted its holdings in shares of Cognex by 0.5% during the 1st quarter. State of Michigan Retirement System now owns 39,853 shares of the scientific and technical instruments company's stock worth $1,952,000 after purchasing an additional 200 shares during the last quarter. Eastern Bank grew its position in shares of Cognex by 20.0% in the third quarter. Eastern Bank now owns 1,242 shares of the scientific and technical instruments company's stock valued at $75,000 after purchasing an additional 207 shares in the last quarter. Personal CFO Solutions LLC grew its position in shares of Cognex by 3.2% in the first quarter. Personal CFO Solutions LLC now owns 6,793 shares of the scientific and technical instruments company's stock valued at $333,000 after purchasing an additional 212 shares in the last quarter. Finally, World Investment Advisors increased its holdings in shares of Cognex by 3.7% in the first quarter. World Investment Advisors now owns 6,073 shares of the scientific and technical instruments company's stock valued at $298,000 after purchasing an additional 214 shares during the last quarter. 88.12% of the stock is currently owned by institutional investors.

Cognex Company Profile

Cognex Corporation NASDAQ: CGNX develops machine vision products and technologies that help businesses automate manufacturing, logistics and other industrial processes. Its systems enable machines to inspect, identify, measure and guide products, components and materials with limited human intervention.

The company's product portfolio includes industrial vision cameras, vision sensors, image-based barcode readers, three-dimensional vision systems and software for image processing and analysis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.